Overall, our study underscores the significance of METTL1 and its role in the m7G modification of ATF4 as a means of regulating cSCC tumor progression, offering a foundation for the further exploration of innovative therapeutic approaches to clinical cSCC treatment. The gene discussed is METTL1; the disease is skin squamous cell carcinoma.